chapter i introduction - shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/17419/8/08_chapter...
TRANSCRIPT
1
CHAPTER I
INTRODUCTION
1.1 Introduction
Schiff base was first reported by Hugo Schiff in 1864 [1]. Compounds
containing an azomethine group (-CH=N-), known as Schiff bases are formed by
the condensation of primary amine with a carbonyl compound. Schiff bases of
aliphatic aldehydes are relatively unstable and are readily polimerizable while those
of aromatic aldehydes, having an effective conjucation system, are more stable.
Though the Schiff bases are stable solids, care should be taken in the purification
steps as it undergoes degradation. Chromatographic purification of Schiff bases on
silica gel is not recommended as they undergo hydrolysis. The common structural
feature of these compounds is the azomethine group with a general formula
RHC=N-R’, where R and R’ are alkyl, aryl, cycloalkyl or heterocyclic groups
which may be variously substituted. Presence of a lone pair of electrons in a sp2
hybridized orbital of nitrogen atom of the azomethine group is of considerable
chemical importance and impart excellent chelating ability especially when used in
combination with one or more donor atoms close to the azomethine group.
Examples of a few ligands are given in Figure 1.1.1.
Salen type, oxime type, macrocyclic type, Robson type, mixed type ligand.
3
Mixed type ligand complexes
Fig 1.1.1 Type of ligands and complexes.
1.1.1 Applications of Schiff base transition metal complexes
1.1.1.1 As electroluminescent materials
Organic electroluminescent (EL) devices are useful in novel-type flat-panel
displays since Tang and Van Styke first reported on high-performance organic EL
devices [2]. Their discovery was based on employing a multilayer device structure
containing an emitting layer and a carrier transport layer of suitable organic
materials. Organic dyes, chelate metal complexes and polymers are three major
categories of materials used in the fabrication of organic EL devices. Out of the
three, chelate metal complexes having high-luminance blue emitting nature find use
as materials for RGB (red, green, and blue) emission. Schiff base complexes,
especially those of Zn(II), are now a day’s used as electroluminescent materials
[3, 4]. Zinc complex of the Schiff base, N,N’-bis(2-hydroxy-1-naphthylidene)-3,6-
dioxa-1,8-diaminooctane, emits blue light with an emission peak at 455 nm having
maximum brightness of 650 cd m−2
, when it is used as the emitting layer in an
electroluminescence device. Fabrication of EL devices employing this kind of zinc
complexes as blue electroluminescent material was carried out by thermal vacuum-
4
deposition. Wei et al. prepared blue luminescent zinc and beryllium complexes of
the Schiff bases derived from calixarene [5]. These Schiff base complexes have
good solubility in normal solvents and can easily form thin films. Xie et al. reported
the crystal structure, thermal stability and optoelectronic properties of bis
[salicylidene (4-dimethylamino) aniline] zinc(II) [6]. This complex exhibits very
good light emission and charge transporting performance in organic light emitting
diodes (OLEDs). These experimental reports point to the possible application of
Schiff base complexes as emitting materials in full colour flat-panel displays.
1.1.1.2 In non-linear optical devices
Nonlinear optics (NLO) deals with the interactions of applied
electromagnetic fields with various materials to generate new electromagnetic
fields, altered in frequency, phase, or other physical properties. Such materials that
are able to manipulate photonic signals efficiently are of importance in optical
communication, optical computing, and dynamic image processing [7-11]. In this
connection transition metal complexes have emerged as potential building blocks
for nonlinear optical materials due to the various excited states present in these
systems as well as due to their ability to tailor metal-organic-ligand interactions
[12-17]. Compared to the more common organic molecules, the metal complexes
offer a large variety of novel structures, the possibility of enhanced thermal
stability, and a diversity of tunable electronic behaviors by virtue of the coordinated
metal center and hence they may find use as NLO materials with unique magnetic
and electrochemical properties [18-20]. The investigations on NLO properties of
metal complexes are being pursued by several research groups [21-27]. It has been
5
reported by Di Bella and co-workers that bis (salicylaldiminato) metal Schiff base
complexes exhibit good second order NLO properties [28-34].
1.1.1.3 In electrochemical sensors
Schiff bases have been used as carriers in the preparation of potentiometric
sensors for determining cations and anions [35-44]. A ruthenium(III) Schiff base
complex was used in the fabrication of chloride PVC-based membrane sensor [45].
The sensor with a composition of 30 % PVC, 62 % benzyl acetate, 5 %
ruthenium(III) Schiff base complex and 3 % hexadecyltrimethyl ammonium
bromide displays near-Nernstian behavior over a wide concentration range. It
shows high selectivity towards chloride ions over several organic and inorganic
anions and was successfully applied for the determination of chloride in serum
samples. It could also be used as an indicator electrode in the potentiometric
titration of chloride ions with silver nitrate solution. Gupta et al. recently reported a
potentiometric aluminium sensor based on the use N, N’-bis (salicylidene)-1, 2-
cyclohexanediamine as a neutral carrier in poly (vinyl chloride) matrix [46]. It was
successfully applied for direct determination of aluminium(III) in biological,
industrial and environmental samples. The electrode could be used in the pH range
of 2.0–9.0 and mixtures containing up to 20 % (v/v) non-aqueous content. It has
been used as an indicator electrode in potentiometric titration of aluminium ion with
EDTA. The Schiff base, N, N′, N″, N′′′-1, 5, 8, 12-tetraazadodecane-bis
(salicylaldiminato), has been used as ionophore for preparing Mn2+
selective sensor
[47]. The sensor was found to be sufficiently selective for Mn2+
over a number of
alkali, alkaline and heavy metal ions and could therefore be used for the
determination of manganese in various samples by direct potentiometry.
6
1.1.1.4 In catalytic activity
Many Schiff base complexes show excellent catalytic activity in various
reactions at high temperature (>100 °C) and in the presence of moisture. The
interest in polymerization of olefins has increased recently due to the observed
catalytic activity of Schiff base complexes in synthesis of commercially important
branched [48, 49] and linear polyethylene [50-53]. The ring opening polymerization
of cycloalkenes with transition metals such as tungsten, molybdenum and
ruthenium in the presence of alkylation agents such as R4Sn or RAlCl2 is possible at
high temperature without any control on molecular weight of polymers. But Schiff
base complex catalyzed ring opening polymerization of cycloalkenes at low
temperature provided a control on the molecular weight of the polymers [54]
without any side reaction. The ring opening of large cycloalkanes is usually a
difficult process but Schiff base complexes of cobalt(II) [55] and chromium(III)
were effective in these reactions with significant enantioselectivity. Phosphine
substitution in N-heterocyclic carbene Schiff base ligand has enhanced ring closing
metathesis reaction to synthesize functionalized olefins [56]. Schiff base complexes
showed significant applications in reduction of ketones to alcohols [57] and
alkylation of allylic substrates [58, 59]. The phosphine Schiff base complexes also
showed improved enantioselectivity in hydrosilation reactions [60]. The chiral
Schiff base complexes of salen [61] and binaphthyl were used as efficient catalysts
in Michael addition reaction. Although the heteroannulation reaction is reported
using transition metal complexes [62, 63] a new catalytic route for annulation
reaction using Schiff base complexes has been an area of current research [64].
Schiff base complexes showed catalytic activity in carbonylation of alcohols and
7
alkenes at low pressure to produce α-arylpropionic acid and their esters [65, 66],
which are used as non-steroidal anti-inflammatory drugs. In addition to
monometallic, the bimetallic Schiff base complexes also showed catalytic activity
in carbonylation reactions [67]. The Heck reaction, an industrially useful process to
synthesize fine chemicals and pharmaceutical, was successfully catalyzed using
Schiff base complexes [68-70]. The complexes of nickel(II) and copper(II) ions
have increased enantioselectivity in alkylation of enolates [71-74]. The
enantiomeric synthesis of aziridines and amides with chiral metalolloporphyrins
was moderate [75-76] but improved in the presence of Schiff base complexes of
copper(II) and manganese(III) [77]. The isomerization of norbornadiene to
quadricyclane was significantly catalyzed using diimine complexes of rhodium
[78]. These interconversions were useful for the storage of solar energy. The
aluminium–salen Schiff base complexes were also used in catalyzing the addition
of hydrogen cyanide to N-allylbenzaldimine, which showed significant
enantiomeric excess [79]. The enantioselectivity in the cyclopropanation reactions
was modest; hence, attempts were also made to improve enantioselectivity in the
cyclopropanation reactions using Schiff base complexes as catalysts [80-81]. The
optically active cyanohydrins are widely used in the synthesis of drugs and
pesticide. These cyanohydrins were synthesized successfully reacting trimethyl
silylcyanide (TMSCN) with aldehydes in the presence of Schiff base complexes of
transition metal ions [82]. Schiff base complexes also played a significant role in
desymmetrization of meso compounds with significant yield and enantiomeric
excess [83]. The homogeneous chiral lanthanum(III) Schiff base complexes showed
8
catalytic activity in asymmetric Diels–Alder reactions [84] and product yield and
enantioselectivity were influenced by the nature of catalysts [85].
1.1.1.5 As corrosion inhibitor
Aggressive acid solutions are widely used for industrial purposes, and
inhibitors are commonly used to control metal dissolution as well as consumption.
Most acid inhibitors are organic compounds containing oxygen, nitrogen and/ or
sulphur [86-90]. Acid inhibitors have many important roles in the industrial field as
components in pre-treatment composition, cleaning solutions and in acidisation of
oil wells. Compounds with functional groups containing hetero-atoms, which can
donate lone pairs of electrons are found to be particularly useful as inhibitors of
metal corrosion [91, 92]. In Schiff bases the condensation product of an amine and
ketone or aldehyde with general formula of R2C=NR is well-known organic
inhibitors [93-94]. Some research work revealed that the inhibition efficiency of
Schiff bases is much greater than that of corresponding amines and aldehydes and
attributed this to the presence of an –HC=N– group in the molecules [95]. The
action of such inhibitors depends on the specific interaction between the functional
groups and the metal surface. So it is very important to clarify the interactions
between inhibitor molecules and metal surfaces in order to search new and efficient
corrosion inhibitors. The main results showed that some mechanical properties
depend on the electronic and structural properties of the inhibitor molecule such as
aromatic and functional groups, electron density on donor atoms and k orbital
character of donating electrons.
9
1.1.1.6 In medicinal chemistry
The treatment of a variety of cancers by cisplatin, cis-[Pt(NH3)2Cl2], has
investigated the on-going investigations of alternative metal-based drugs. The initial
discovery of the anti-tumor activity of platinum complexes was made by Barnett
Rosenberg’s [96] research group in the 1960’s. They were studying the effects of an
electric current passed over platinum electrodes immersed in a solution containing
Escherichia coli cells that were growing in the presence of an ammonium chloride
buffer. Interesting enough was that cell growth continued but division of the cells
was greatly inhibited. It was found from tests that the platinum had reacted with
NH4Cl to form an active compound, cis-[Pt(NH3)2Cl2] (cisplatin) of which the
synthesis and structure were well known from time to time. Tests were done on
cisplatin proving that it has beneficial effects on the treatment of cancer [97]. The
biological activity results from binding to the DNA, thus inhibiting replication.
Today, cisplatin is used in combination with other anticancer agents and is effective
against testicular and ovarian carcinomas, bladder cancer and tumors of the head
and neck.
Anti-cancer drugs have many side effects, like renal toxicity for cisplatin,
which then restrict them to limited doses. Damage to bone marrow causes anemia,
which is an inability to fight infections and a tendency to internal bleeding. Other
side effects include vomiting, diarrhea, nausea, hair loss and neurological
complications. Another drawback that can be encountered in using drugs is the fact
that the tumor can develop resistance to other drugs after the first administration.
10
Copper is a physiologically important metal element that plays an important
role in the endogenous oxidative DNA damage associated with aging and cancer
[98]. Among the copper complexes explored so far, attention has been mainly
focused on the copper(II) complexes of 1,10-phenanthroline ligand due to their high
nucleolytic efficiency [99] and numerous biological activities such as antitumor
[100], anti-candida [101],and antimicrobial [102,103] activities, etc., These
complexes have also been widely utilized as foot printing agents of both proteins and
DNA [104], probes of the dimensions of the minor groove of duplex structures [105],
and identifiers of transcription start sites [106]. Recently, it has been reported that a
binuclear copper(II) complex containing 1, 10-phenanthroline and a trinuclear
copper(II) complex containing di-(2-picolyl) amine bind strongly with DNA and
cleave more effectively than their corresponding monomeric complexes [107-110].
The bis-(phen)copper complex is proposed to bind to DNA by partial intercalation of
one phenanthroline ring, while the other makes favorable contacts in the minor
groove [111]. The reports by Burrows et al. [112] advocate design studies on metal
complexes with nitrogen-donor ligands that can participate in both hydrogen bonding
and interactions for molecular recognition and crystal engineering applications.
Copper chemistry
Copper is one of the most abundant metals in the earth’s crust and it has
been known for many centuries. The word copper is derived from Cyprus where
many ancient copper objects were discovered. It can be found in its pure state and
was probably the first metal from which useful articles were made. Copper is an
important trace element in almost all forms of life and it is the third most abundant
element in the human body following iron and zinc.
11
Copper (II) oxidation state
The copper(II) oxidation state is by far the most common for copper.
Copper(II) complexes have an outer electronic configuration of [Ar] 3d9 4s
0, are
paramagnetic, and are mostly blue or green in color. The coordination number for
copper(II) complexes are usually four, five, and six, with tetrahedral, square planar,
trigonal bipyramidal and octahedral structures commonly found. Electronic spectra
of simple copper(II) complexes contain broad absorption bands in the region of
900-625 nm. Because of the distortion of the octahedral geometry the crystal field is
split, and thus the electronic bands are very difficult to assign in ambiguously. The
theoretical spin-only values for copper(II) lies between 1.75-2.20 B.M are obtained
experimentally [113]. Regardless of temperature (except at extremely low values)
those compounds with geometries approaching octahedral have moments at the
lower end, and those with tetrahedral geometry have values at the higher end.
Medicinal properties of copper compounds
An average adult has 1.4-2.1 mg of copper per Kg of body weight. Copper
is required in the body for hemoglobin synthesis, growth, keratinisation,
pigmentation, bone formation, reproduction, fertility, development and sightedness.
These roles of copper are based upon the requirement of coordinated copper at the
active site of the following copper-dependent enzymes: ceruloplasmin, tyrosinase,
lysyl oxidase, ceramide galactosyl transferase; cytochrome-c-oxidase, dopamine-β-
hydrolyse, pyridoxal requiring monoamine oxidases and a superoxide dismutase.
The use of a copper coil as an intrauterine device to regulate fertility has
been common for many years. Osterberg pointed out that this method of
12
contraception prefers many advantage over oral ones, more efficient contraception
resulting in fewer pregnancies, and greater tolerance, as shown by less pain,
bleeding, spontaneous expulsion and infection. The copper device may have
another advantage over the plain one in that the gonococcidal action of copper may
prevent the spread of gonorrheal infection to the uterus. The mechanism of this anti-
fertility effect is not well established, however , it is likely that copper complexes
formed by the reaction of the uterine contents with either Cu(I) or Cu(II) leached
from the metallic copper coil by endometrial fluids, are absorbed and induce a urine
state of pseudo pregnancy[114].
In the 1920’s it was recognized that the incidence of tuberculosis was much
less in copper miners than in the general population. This led to the successful use
of copper oxide in the treatment of tuberculosis before 1940. Several additional
copper complexes were reported to have antitubercular activity and the complex
sodium 3-(allylcuprothiouredo)-1-benxoate (Fig) was suggested to be more potent
than gold as therapy for tuberculosis [114].
Figure 1.1.1.1 The anti tubercular complex sodium 3--(allylcuprothiouredo)-1-
benxoate.
It is well known that copper(II) complexes of inactive ligands and anti-
inflammatory organic drugs are generally more active than the free ligands or organic
drugs themselves [115]. The most widely used anti-inflammatory drugs are carboxylic
13
acids. For example, salicylic acid and its derivatives have been used for the treatment of
inflammatory diseases for many years. It has been suggested that the biological activity
of acetylsalicylic acid (aspirin) is due to its ability to form metal complexes, and that
the active form of this drugs was, in fact, a copper complex, formed in vivo. The
synthesized copper(II) complex of aspirin (Cu2(O2CC6H4OCOCH3)4] [116] has been
found to be more effective than aspirin itself as an anti-inflammatory agent. In addition,
the copper complex also has antiulcer activity, which further distinguishes it from
aspirin which itself is ulcerogenic. [Cu2(O2CC6H4OCOCH3)4] has been found to be
effective in the treatment of rheumatoid disorders, and it reduces seizures and decreases
tumor growth. The pyridine adduct [Cu2(O2CC6H4OCOCH3)4(C5H5N) 2] has also been
found to be an effective anti-inflammatory, anticancer and anticonvulsant agent [117].
Figure 1.1.1.2 (a) Acetylsalicylic acid (aspirin); (b) structure of
[Cu2(O2CC6H4OCOCH3)4].
The potential of copper carboxylates as pharmacologic compounds has
prompted research into their physico-chemical properties. In 1984, Greenaway et
al., [117] structurally characterized the mononuclear copper(II) bis (pyridine)
acetylaceta complex [Cu2(O2CC6H4OCOCH3)4(C5H5N)2] which has been found to
be an effective anti-inflammatory, anticancer and anticonvulsant agent [116].
14
Nickel complexes draw much attention due to the environmental toxicity
and carcinogenic nature of certain nickel compounds and the chemotherapeutic
properties of other group VIII metal complexes [117]. Some researchers have
shown that bound proteins or synthetic ligands may increase the toxic effect of
nickel ions. However, till now, the exact mechanism to involve carcinogenesis has
not been fully elucidated [118]. The elucidation of the mechanism is essential not
only for the risk assessment [119], but also for developing novel nickel complexes
that have potential applications in medicine and research, such as inhibitors of
cancer proliferation and useful DNA or RNA probes [120, 121]. Therefore, further
studies by employing various ligands with different structures to evaluate and
understand those factors that can determine the DNA binding modes and cleavage
mechanism are necessary. Schiff base complexes present suitable biometric
properties that can mimic the structural features of the active sites, and they have
been widely used in various fields such as illness treatment, biochemical reaction
and biological regulator [122]. Muller et al., systematically investigated ligand
effects, such as ring size, redox potential, ligand donor strength and conformational
flexibility of tetraazamacrocyclic nickel(II) complexes on their DNA cleavage
abilities [117]. Such studies may define the important criteria for design of nickel-
based reagents as structural probes of nucleic acid. It has been widely reported that
the interaction between metal complexes and DNA, such as electrostatic interaction,
intercalative binding, and groove binding, may have great effects on the DNA
cleavage activities of the metal complexes. Systematic investigation of these factors
on the DNA cleavage activities of tetraazamacrocyclic Schiff base nickel(II)
15
complexes may supplement important information for design of nickel base DNA
probes.
Manganese, an essential element for human, is widely distributed in nature and
is second in terms of its terrestial abundance among the first row transition metals
[123]. In biosystem several enzymes namely superoxide dismutase (SOD) [124],
oxalate oxidase [125], lipoxygenase (LO) [126], catalase [127] etc. require manganese
as cofactor for their catalytic activities. In biological reactions manganese sometime
acts as a Lewis acid, on the other hand, it could participate in redox reactions by
flipping its +2, +3 and +4 oxidation states. Hence it has plural roles in biosystem.
However, the role of manganese in oxygen evolving complex (OEC) of photosystem-II
(PSII) is unique [128]. Coordination chemistry of manganese has been exploited for the
structural and functional modeling of metalloprotein e.g. mimicking of OEC in PSII
[129]. Other applications are catalytic activity studies [130] and synthesis of
photolabile metal nitrosyl complexes [131]. Stabilization of manganese oxidation states
has been implicated in manganese toxicity [132]. However, the curiosity originated
from the great demand of manganese chemistry with ligands having phenolato donors
for the mimicking of SOD activity. Moreover, it has been documented in the literature
that native SOD as well as small molecule SOD mimics exhibit nuclease activity
[133, 134]. Hence the researcher was also interested to study DNA interaction as well
as nuclease activity studies.
Cobalt complexes have shown anti-malarial effects [135] where they target
the plasmodium parasite. The activity of the compounds was comparable to that of
the currently used drug, amodiaquine, at similar concentrations. These studies were
in vitro studies and only show the toxicity to the parasite not the host. No further
16
biological testing information was reported. Other studies have shown cobalt
complexes to have anti-bacterial activity which is also comparable to the presently
available drug, imipenium [136]. These results were also done in vitro and there is
no mention of further biological testing on these compounds. Cobalt is a redox
active metal where the +2 and +3 oxidation states are most common.
17
References
1. H. Schiff, Annalen. 3 (1864) 343.
2. C.W. Tang, S.A.Vanslyke, App. Phy. Lett. 51 (1987) 913.
3. T.Yu, W.Su, W.Li, Z. Hong, R.B. Hua, B. Li, Thin solid Films. 515 (2007)
4080.
4. Y. Yi, X.Q. Wei, M.G. Xie, Z.Y. Lu. Chinese. Chem. Lett. 15 (2004) 525.
5. X. Q. Wei, Z.Y. Lu, P. Zou, M.G. Xie, Chinese. Chem. Lett. 14 (2003) 263.
6. J. Xie, J. Qiao, L.Wang, J. Xie, Y. Qiu. Inorg. Chem. Acta 358 (2005) 4451.
7. D.R. Kanis, M.A. Ratner, T. J. Marks. Chem. Rev. 94 (1994) 195.
8. L.R. Dalton, A.W. Harper, R. Ghosn, W.H. Steier, M. Ziari, H. Fetterman,
Y. Shi, R.V. Mustacich, A.K.Y. Jen, K. Shea. J. Mat. Chem. 7 (1995) 1060.
9. R.G. Benning, J. Mat.Chem. 5 (1995) 365.
10. S.R. Marder, D.N. Beratan, L.T. Cheng, Science 252 (1991) 103.
11. T.Verbiest, S. Houbrechts, M. Kauranen, K. Clays, A. J. Persoons,
Mat.Chem. 7 (1997) 2175.
12. N.J. Long, Angewandte Chemie International Edition 34 (1995) 21.
13. M. Bourgault, C. Mountassir, H. Le Bozec, I. Ledoux, G. Pucetti, J. Zyss.
J. Chem. Soc., Chem.Commun. (1993) 1623.
14. S. Di Bella, I. Fragata, I. Ledoux, M.A. Draz-Garcia, P.G. Lacroix, T.Marks,
J. Chem. Mat. 6 (1994) 881.
15. W.M. Laidlaw, R.G. Denning, T. Verbiest, E. Chauchard, A. Persoons.
Nature, 363 (1994) 58.
16. B.J. Coe, J.D. Foulon, T.A. Hamor, C.J. Jones, J.A. McCleverty, D. Bloor,
G.H. Cross, T.L. Axon, J. Chem.Soc., Dalt.Trans. (1994) 3427.
18
17. H.S. Nalwa. App. Org. met.Chem. 5 (1991) 349.
18. G.L. Geoffroy, M.S. Wrighton. Organometallic Photochemistry, Academic
Press, New York, 1979.
19. J.P. Collman, L.S. Hegedus. Principles and Applications of Organotransition
Metal Chemistry, University Science Books, Mill Valley, CA, 1987.
20. O. Kahn, Molecular Magnetism, VCH Publishers, New York, 1993.
21. S. Di Bella, Chem. Soc., Rev. 30 (2001) 355.
22. P.G. Lacroix. Eur. J. Inorg. Chem. (2001) 339.
23. C.E. Powell, M.G. Humphrey, Coord.Chem. Rev. 248 (2004) 725.
24. B.J. Coe, J.A. Harris, L.A. Jones, B.S. Brunschwig, K. Song, K. Clays,
J. Garin, J.Orduna, S.J. Coles, M.B.Hursthouse, J. Am. Chem. Soc. 127,
(2005) 4845.
25. B.J. Coe, J.A. Harris, B.S. Brunschwig, Asselberghs, A.I.K. Clays, J.Garin,
J. Orduna. J. Am. Chem. Soc. 127 (2005) 13399.
26. B.J. Coe, J.A. Harris, L.A. Jones, B.S. Brunschwig. Dalton Trans. (2003)
2384.
27. D.R. Kanis, M.A. Ratner, T. Marks, J. Chem. Rev. 94 (1994)195.
28. S. Di Bella, I. Fragala, I.Ledoux, T.J. Marks, J. Am. Chem. Soc. 117 (1995)
9481.
29. S. Di Bella, I. Fragala, T.J. Marks, M.A. Ratner, J. Am. Chem. Soc. 118
(1996) 12747.
30. P.G. Lacroix, S. Di Bella, I. Ledoux, Chem. of. Mat. 8 (1996) 541.
31. S. Di Bella, I. Fragala, I. Ledoux, M.A. Diaz-Garcia, J. Marks,
J. Am. Chem. Soc., 119 (1997) 9550.
19
32. G. Lenoble, P.G. Lacroix, J.C. Daran, S. Di Bella, K. Nakatani, Inorg. Chem.
37 (1998) 2158.
33. S. Di Bella, I. Fragala, A. Guerri, P. Dapporto, K. Nakatani, Inorg. Chim.
Acta 357 (2004) 1161.
34. F. Averseng, P.G. Lacroix, I. Malfant, G. Lenoble, P. Cassoux, K. Nakatani,
I. Maltey- Fanton, J.A. Delaire, A. Aukauloo, Chem. Mat. 11 (1999) 995.
35. T. Shamspur, I. Sheikhshoaie, M.H. J. Mashhadizadeh, Anal. Atom. Spect. 20
(2005) 476.
36. S. Sadeghi, M. Eslahi, M.A. Naseri, H. Naeimi, H. Sharghi, A. Shameli,
Electroanal. 15 (2003) 1327.
37. M. H. Mashhadizadeh, I. Sheikhshoaei, S. Saeid-Nia, Sen. Actu. B chem. 94
(2003) 241.
38. R.K. Mahajan, I. Kaur, M. Kumar, Sen. Actu. B. chem. 91 (2003) 26.
39. M.H. Mashhadizadeh, I. Sheikhshoaei, Anal. Bioanal. Chem. 375 (2003) 51.
40. L. P. Singh, J. M. Bhatnagar, Talanta 64 (2004) 313.
41. A.R. Fakhari, T.A. Raji, H. Naeimi, Sens. Actu. B chem. 104 (2005) 317.
42. T. Jeong, H.K. Lee, D.C. Jeong, S. Jeon, Talanta 65 (2005) 543.
43. M. Shamsipur, M. Yousefi, M. Hosseini, M.R. Ganjali, H. Sharghi,
H. Naeimi, Anal. Chem. 73 (2001) 2869.
44. M.R. Ganjali, T. Poursaberi, M. Hosseini, M. Salavati-Niasari, M. Yousefi,
M. Shamsipur, Analytical Sciences 18 (2002) 289.
45. M.R. Ganjali, M.R. Pourjavid, M. Rezapour, T. Poursaberi, A. Daftari,
M. Salavati-Niasari, Electroanal. 16 (2004) 922.
20
46. V.K. Gupta, R.N. Goyal, A.K. Jain, R.A. Sharma, Electrochim. Acta 54
(2009) 3218.
47. V.K. Gupta, A.K. Jain, G. Maheshwari, Talanta 72 (2007) 49.
48. Z. Guan, P.M. Cotts, E.F. McCord, S. J. McLain, Science 283 (1999) 2059.
49. S. Plentz-Meneghetti, J. Kress, P.J. Lutz, Macromol. Chem. Phys. 201 (2000)
1823.
50. B.L. Small, M. Brookhart, A.M.A. Bennett, J. Am. Chem. Soc. 120 (1998)
4049.
51. G.J.P. Britovsek, V.C. Gibson, B.S. Kimberley, P.J. Maddox, S.J. McTavish,
G.A. Solan, A.J.P. White, D. J. Williams, Chem. Commun. (1998) 849.
52. B.L. Small, M. Brookhart, Macromolecules 32 (1999) 2120.
53. E.A.H. Griffiths, G.J.P. Britovsek, V.C. Gibson, I.R. Gould, Chem. Commun.
(1999) 1333.
54. J.P. Claverie, R. Soula, Prog. Polym. Sci. 28 (2003) 619.
55. E.N. Jacobsen, F. Kakiuchi, R.G. Konsler, J.F. Larrow, M. Tokunaga,
Tetrahedron Lett. 38 (1997) 73.
56. A.K. Chatterjee, M. Schoel, G.H. Grubbs, J. Am. Chem. Soc. 122 (2000)
3783.
57. Kim, W.S. Choi, Y.K. Appl. Catal. A. Gen. 252 (2003)163.
58. T. J. Hayashi, Organomet. Chem. 576 (1999) 195.
59. H. Brunner, I. Demi, W. Dirnberger, B. Number, W. Reiber, Eur. J. Ing.
Chem. (1998), 43.
60. H. Nishiyama, H.K. Itoh, I. Ojima Catalytic Asymmetric Synthesis, Wiley-
VCH, New York, 2000, p. 1.
21
61. H. Brunner, C. Krumey, J. Mol. Catal. A. Chem. 142 (1999) 7.
62. R.C. Lorock, T.R. Hightower, L.A. Hasvold, K.P. Peterson, Org. Chem. 61
(1996) 3584.
63. M. Beler, O.R. Thiel, H. Trauthwein, C.G. Hartung, Chem. Eur. J. 6 (2000)
2513.
64. A.R. Katritzky, M. Arend, J. Org. Chem. 63 (1998) 9989.
65. H.Y. Zhou, J. Cheng, S.J. Lu, H.X. Fu, H.Q. Wang, J. Organomet.Chem. 556
(1998) 239.
66. E.J. Jang, K.H. Lee, J.S. Lee, Y.G. Kin, J. Mol. Catal. A. Chem. 144 (1999)
431.
67. B.S. Wah, S.J. Liao, Y.Xu, D.R. Xu, J. Mol. Catal. A. Chem. 136 (1998) 263.
68. J. Tsuji, Palladium Reagents and Catalysts, Wiley, New York 1996.
69. W.A. Herrmann, B. Cornil, W.A.Hermann Applied Homogeneous Catalysis
with Organometallic Compounds, 2nd
edition, Wiley-VCH, Weinhein, 2002,
p. 775.
70. M. Bhal Chandra, S.F. Bhanage, A. Masahiko, J. Organomet. Chem. 687
(2003) 211.
71. B. Lygo, J. Crosby, J.A. Peterson, Tetrahedron Lett. 40 (1999) 8671.
72. E.J. Carey, Y. Bo, J. Busch Peterson, J. Am. Chem. Soc. 120 (1998) 13000.
73. M. Nakogi, T. Kanayama, T.Okino, Y J. Takemoto, Org. Chem. 67 (2002)
7418.
74. G. Chen, Y. Deng, L. Gong, A. Mi, X. Cui, Y. Jiang, M.C.K. Choi,
A.S.C. Chan, Tetrahedron Assym. 12 (2001) 1567.
75. S.M. Au, J.S. Huang, C.M. Che, W.Y. J. Yu, Org. Chem. 65 (2000) 7858.
22
76. J.P. Simonato, J. Pecout, W.R. Scheidt, J.C. Morchon, Chem. Commun.
(1999) 989.
77. Y. Kolmura, T. Katsuki, Tetrahedron Lett. 42 (2001) 3339.
78. C.Tarro, S. Kato, A. Evenzahav, S.H. Bossrnam, J.K. Barton, M.J. Turro,
Inorg. Chim. Acta 243 (1996) 101.
79. M.S. Sigman, E.N. Jacobson, J. Am. Chem. Soc. 120 (1998) 5315.
80. H.L. Kwang, W.S. Lee, Tetrahedron Asym. 11 (2000) 2299.
81. H. Kanemasa, S. Hamura, E. Hanara, H. Yamamoto, Tetrahedron Lett. 35
(1994) 7985.
82. W.D. Pan, X.M. Feng, L.Z. Gong, W.H. Hu, Z. Li, A.Q. Mi, Y.Z. Hang,
Synlett. (1996) 337.
83. P. M¨uller, P. Nury, Helv. Chim. Acta 84 (2001) 662.
84. K.Mikani, M.Terada, H. Matsuzawa, Angew. Chem. Int. Ed. 41 (2002) 3554.
85. S.E. Schaus, J. Branalt, E.N. Jacobson, J. Org. Chem. 63 (1998) 403.
86. S.S. Abd El Rehim, M.A.M. Ibrahim, K.F. Khalid, J. Appl. Electrochem. 29
(2002) 593.
87. J.M. Sykes, J. Corros. 25 (1990) 175.
88. S. Rengamani, S. Muralidharan, M. Anbu Kulamdainathan, S.Venkatakrishna
Iyer, J. Appl. Electrochem. 24 (1994) 355.
89. M. Ajmal, A.S. Mideen, M.A. Quraishi, Corros. Sci. 36 (1994) 79.
90. A. El-Sayed, J. Appl. Electrochem. 27 (1992) 193.
91. N.A. Negm, S.M.I. Morsy, Corrosion. J. Surf. Det. 8(3) (2005) 283.
92. K.C. Emregul, A.A. Akay, O. Atakol, Mater. Chem. Phys. 93 (2005) 325.
23
93. M.Hosseini, S.F.L. Mertens, M. Ghorbani, M.R. Arshadi, J. Appl.
Electrochem. 38 (2003) 1629.
94. Y.A. Balaban, S. Kandemir, G. Bereket, Y. Erk, Mat. Chem. Phys. 85 (2004)
420.
95. Y.K. Agrawal, J.D. Talati, M.D. Shah, M.N. Desai, N.K. Shah, Corros Sci. 46
(2004) 633.
96. B. Rosenberg, L. Van Camp, J.E. Trosko, V.H. Mansour, Nature 22 (1969)
385.
97. M.P. Hacker, E.B. Douple, I.H. Krakoff, Platinum Coordination Complexes
in Cancer Chemotherapy Edition. Martinus Nijhoff, Boston, 1984.
98. B.N. Ames, M.K. Shigenaga, T.M. Hagen, Proc. Natl. Acad. Sci. USA, 90
(1993) 7915.
99. D.S. Sigman, Biochem. 29 (1990) 9097.
100. J.D. Ranford, P. Sadler, J. Dalton Trans. (1993) 3393.
101. G. Majella, S. Vivienne, M. Malachy, D. Michael, M. Vickie, Polyhedron 18
(1999) 2931.
102. J.D. Saha, U. Sandbhor, K. Shirisha, S. Padhye, D. Deobagkar, C.E. Ansond,
A.K. Powelld, Bioorg. Med. Chem. Lett. 14 (2004) 3027.
103. M.A. Zoroddu, S. Zanetti, R. Pogni, R. Basosi J. Inorg. Biochem. 63 (1996)
291.
104. M.D. Kuwabara, C. Yoon, T.E. Goyne, T. Thederahn, D.S. Sigman,
Biochem. 25 (1986) 7401.
105. J.A. Cowan, Curr. Opin. Chem. Biol. 5 (2001) 634.
24
106. T.B. Thederahn, A. Spassky, M.D. Kuwabara, D.S. Sigman, Biochem.
Biophys. Res. Commun. 168 (1990) 756.
107. Q.G. Zhang, F. Zhang, W.G. Wang, X.L. Wang, J. Inorg. Biochem. 100
(2006) 1344.
108. Y. Ni, D. Lin, S. Kokot, Anal. Biochem. 352 (2006) 231.
109. M. Komiyama, S. Kina, K. Matsumura, J. Sumaoka, S. Tobey, V.M. Lynch,
Anslyn, E. J. Am. Chem. Soc. 124 (2002) 13731.
110. T. Gupta, S. Dhar, M. Nethaji, A.R. Chakravarty, Dalton Trans. (2004) 1896.
111. O. Zelenko, J. Gallagher, D.S. Sigman, Angew. Chem. Int. Ed. Engl. 36
(1997) 2776.
112. A.D. Burrows, C.W. Chan, M.M. Chowdhry, J.E. McGrady, D.M.P. Mingos,
Chem. Soc. Rev. 24 (1995) 329.
113. N.N. Greenwood, A. Earnshaw, Chemistry of the Elements, Pergamon Press,
Oxford, 1984.
114. N.J. Brich, Uses of Inorganic chemistry in medicine, Royal Society of
Chemistry, 1999, p. 11.
115. J.R.J. Sorenson, Metal Ions in Biological Systems, 77 (Edition.H.Siegel),
Marcel- Marcel- Dekker Inc., Newyork, 1982, p. 14.
116. D.H. Brown. W.E. Smith, J.W. Teape A.J. Lewis, J. Med. chem. 23 (1980)
729.
117. J.G. Muller, X. Chen, A.C. Dadiz, S.E. Rokita, C.J. Burrows, J. Am. Chem.
Soc. 114 (1992) 6407.
118. S.S. Matkar, L.A. Wrischnik, P.R. Jones, Hellmann-Blumberg, U. Biochem.
Biophys. Res. Commun. 343 (2006) 754.
25
119. H. Lu, X. Shi, M.Costa, C. Huang, Mol. Cell. Biochem. 279 (2005) 45.
120. M.C. Rodrı`guez-Argu¨ elles, M.B. Ferrari, F. Biscegli, C. Pellizi, G. Pelosi,
S. Pinelli, M. Sassi, J. Inorg. Biochem. 98 (2004) 313.
121. Z. Afrasiabi, E. Sinn, W. Lin, Y. Ma, C. Campana, S. Padhye, J.Inorg.
Biochem. 98 (2005) 1526.
122. L.Z. Li, C. Zhao, T. Xu, H.W. Ji, Y.H.Yu, G.Q. Guo, H. Chao, J.Inorg.
Biochem. 99 (2005) 1076.
123. D.W. Christianson, Prog. Biophys. Mol. Biol. 1993, 67, 217.
124. J.J.R. Frausto da Silva, R.J.P. Williams, The Biological Chemistry of the
Elements, Clarendon Press, Oxford, 1993, p. 4.
125. E.J. Woo, J.M. Dunwell, P.W. Goodenough, A.C. Marvier, R.W. Pickersgill,
Nat. Struct. Biol. 7 (2000) 1036.
126. C. Su, E.H. Oliw, J. Biol. Chem. 273 (1998) 13072.
127. T.L. Stemmler, B.E. Sturgeon, D.W. Randall, R.D. Britt, J.E. Penner-Hahn,
J. Am.Chem. Soc. 119 (1997) 9215.
128. V.L. Pecoraro, Manganese Redox Enzymes, VCH, New York, 1992.
129. S. Mukhopadhyay, S.K. Mandal, S. Bhaduri, W.H. Armstrong, Chem. Rev.
104 (2004) 3981.
130. G. Yin, A.M. Danby, D. Kitko, J.D. Carter, W.M. Scheper, D.H.Busch, Inorg.
Chem. 46 (2007) 2173.
131. K. Ghosh, A.A. Eroy-Reveles, B. Avila, T.R. Holman, M.M. Olmstead,
P.K. Mascharak, Inorg. Chem. 43 (2004) 2988.
132. L. Quintanar, Inorg. Chim. Acta 361 (2008) 875.
26
133. W. Jiang, Y. Han, Q. Pan, T. Shen, C. Liu, J. Inorg. Biochem. 101 (2007)
667.
134. M. Devereux, D.O. Shea, A. Kellett, M. McCann, M. Walsh, D. Egan,
C. Deegan, K. Kedziora, G. Rosair, H. Muller-Bunz, J. Inorg. Biochem. 101
(2007) 881.
135. H. B. Singh, N. Wasi, Inorg. Chim. Acta. 135 (1987) 133.
136. Z. H. Cohan, A.U. Shaikh, M.M. Naseer, Appl. Organometal. Chem. 20
(2006) 729.
27
1.2 LITERATURE SURVEY
Parimala et al1, have synthesized a new binucleating ligands L [L- N’-R-
bis(methyl-N-(2-pyridinyl)ketoacetamide] where R-ethylene,1,3-propylene, o-phenylene
were prepared by the condensation of 1 equivalents of methyl-N-(2-
pyridinyl)ketoacetamide with the diamines. The binuclear copper(II) complexes of the
type [Cu2L]X4 where X=ClO4–
and [Cu2LX2]X2 where X=Cl- and Br
- were synthesized
by refluxing the ligand with 2 equivalents of Cu(II) salts. Conductivity studies
showed a1:4 electrolytes for perchlorate complexes and a 1:2 electrolyte for chloro
and bromo complexes. Room temperature magnetic studies gave moment for the
complexes in the range 1.08 to1.4 B.M which are less than 1.73 B.M for d9 system.
This shows that there is antiferromagnetic coupling between the two copper centers.
ESR spectra of the complexes show a broad band which is centered at 2299 G and
the g values obtained were in the range 2.09 to 2.14. Electrochemical studies show
a quasi-reversible two electron reduction occurring at the negative potential in the
range -0.25 to 0.7 V. The initial rate constant for the oxidation of catechol to
o-quinone by the complexes are in the range 1.504×10–1
to 3.83 × 10 –1
min-1
.
Fig. 1.2.1.
28
Rajavel2
have synthesized novel binuclear Schiff base metal complexes
derived from 2-aminobenzaldehyde. The synthesized ligand and its complexes were
characterized by physico-chemical methods. The weak anti-ferromagnetic
interactions between two metal centers were proved by magnetic studies.
Fig. 1.2.2.
Williams et al3, have reported a novel ligand derived from salicyaldehyde and
the synthesized ligand, complexes were characterized by various physic-chemical
methods. These compounds induced convulsions, urination and defecation in mice.
Due to the relatively very low toxicity of complexes, its mode of action was
explored. Its proconvulsant action may possibly involve an interaction of
undissociated complex with muscarinic receptors, and is reversed by atropine.
Fig. 1.2.3
29
Saglam et al4, have synthesized a novel homodinuclear Cu(II) complexes
with a novel oxime-type ligand have been prepared and their nucleolytic activities
on pCYTEXP were established by neutral agarose gel electrophoresis. The analyses
of the cleavage products obtained electrophoretically indicate that although the
examined complexes induce very similar conformational changes on super coiled
DNA by converting super coiled form to nicked form than linear form in a
sequential manner as the complex concentration or reaction period is increased.
Metal complex induced DNA cleavage was also tested for inhibition by various
radical scavengers as superoxide dismutase (SOD), azide, thiourea and potassium
iodide. The antioxidants inhibited the nucleolytic activities of the oxime complexes
but SOD afforded no protection indicating that the nucleolytic mechanism involves
of copper and/ or manganese complex-mediated reactive oxygen species such as
hydroxyl radicals being responsible for the oxidative DNA cleavage.
Fig. 1.2.4
Sengottuvelan et al5, have synthesized a new series of binuclear
unsymmetrical compartmental oxime complexes using mononuclear complex [ML]
30
(L=/1, 4-bis [2-hydroxy-3-(formyl)-5-methylbenzyl] piperazine), hydroxylamine
hydrochloride and triethylamine. In this system there are two different
compartments, one has piperazinyl nitrogen’s and phenolic oxygen’s and the other
compartment has two oxime nitrogen’s and phenolic oxygens as coordinating sites.
The complexes were characterized by elemental and spectral analysis.
Electrochemical studies of the complexes show two step single electron quasi-
reversible redox processes at cathodic potential region. For copper complexes
E1pc/0.18 to to/0.62 and E
2pc 1.18 to1.25 V, for nickel complexes E
1pc 0.40 to 0.63
and E2pc1.08 to 1.10 V and reduction potentials are sensitive towards the chemical
environment around the copper and nickel atoms. The nickel(II) complexes undergo
two electrons oxidation. The first one electron oxidation is observed around _/
0.75 V
and the second around _1.13 V. ESR Spectra of the binuclear copper(II) complexes
[Cu2L](ClO4), [Cu2L(Cl)], [Cu2L(NO3)] shows a broad signal at g=2.1 indicating
the presence of coupling between the two copper centers. Copper(II) complexes
show a magnetic moment value of µeff around 1.59 B.M at 298 K and variable
temperature magnetic measurements show a _/2 J value of 172 cm
-1 indicating
presence of anti-ferromagnetic exchange interaction between copper(II) centers.
Fig 1.2.5
31
Tuna et al
6, have reported synthesis of ligand derived from 3-formyl-salicylic
acid, 3-[N-2-(pyridylethyl) formimidoyl] salicylic acid. The synthesis of ligand and
metal complexes were characterized by elemental analysis, molar conductance, UV,
IR, NMR and magnetic studies. The interactions between two metal centers were
proved by magnetic studies.
Fig. 1.2.6.
Srinivasan et al7, have synthesized a bimetallic nickel(II) complex with the
ligand Hsalamp (2-[(4-methylpyridin-2-ylimino)-methyl]-phenol), having the
molecular formula, Ni2C26H22 N4O10Cl2, is synthesized and characterized by
elemental, UV-Vis, IR and EPR studies. The IR spectrum confirms the presence of
coordinated perchlorate ion and the UV-Vis. spectrum substantiates that the
geometry around the metal ion is distorted square pyramidal. In the solvent
methanol, the complex undergoes dissociation indicating the nature of the complex
to be 1: 2 electrolytes. The single crystal EPR studies indicate that the zero-field
splitting is not large and the spectra can be observed even at room temperature, not
so common for a nickel(II) ion. The spin Hamiltonian parameters calculated from
single crystal rotations are: g – 2.377, 2.219, 2.071 and D – 9.7, 4.2 and – 13.9 mT.
32
Optical and electron paramagnetic spectral data have been used to obtain the
parameters Dq, B and C.
Fig. 1.2.7
Bera et al8, have synthesized the low-temperature stoichiometric Schiff base
reaction in air in 3:1 mole ratio between benzaldehyde and triethylenetetramine
(trien) in methanol yields a novel tetraaza m-bis(bidentate) acyclic ligand L. It was
characterized by elemental analysis, IR, EI mass and NMR (1H and
13C) spectra.
The formation of a five-membered imidazolidine ring from the ethylenediamine
backbone as a spacer-cum bridging unit gives rise to a new type of imidazolidine-
bridged ligand. A geometric optimization was made of the synthesized ligand and
its complexes by the method of molecular mechanics (MM2) method in order to
establish the stable conformations. This hitherto unknown tetraaza acyclic ligand
affords new cationic dicopper(I/ I) and dicopper(II/ II) complexes in good yield.
Dicopper(II/ II) complex displays weak d–d transition bands in the visible region,
while dicopper(I/ I) complex displays strong MLCT band in the same region. Both
the dinuclear complexes are of non-intimate nature and show interesting solution
electrochemical behavior. EPR spectral study of m-bis (imidazolidino) bridged
dicopper(II/ II) complex also supports the non-communicative nature of the two
copper centers within the same molecule.
33
Fig. 1.2.8
Karabocek et al9, have reported a new ligand incorporating a dioxime
moiety, (2E, 3E)-3-[(2-{[(1E, 2E)-2-(hydroxyimino)-1-methylpropylidene] amino}
phenyl)imino] butan-2-one oxime, (H2Phmdo) (3) has been prepared by
reacting 2,3-butanedionemono-{O-[4-(1-methyl-2-oxo-propylideneaminooxy)-
2, 3-bis-(1-methyl-2-oxo-propylideneaminooxy-methyl)-but-2-enyl]-oxime} (2)
with 1, 2-phenylenediamine.
Fig. 1.2.9
Karabocek et al10
, synthesized a new dioxime ligand, derived from butane
monoxime. The dioxime ligand and its copper(II) complexes were characterized by
1H-NMR,
13C-NMR, and elemental analyses, magnetic moments, IR and mass
spectral studies. Elemental analyses, stoichiometric and spectroscopic data of the
metal complexes indicated that the metal ions are coordinated to the oxime and
imine nitrogen atoms (>C=N). In the dinuclear complexes, in which the first Cu(II)
ion was complexed with nitrogen atoms of the oxime and imine groups, the second
34
Cu(II) ion is ligated with dianionic oxygen atoms of the oxime groups and is linked
to the 1, 10-phenanthroline nitrogen atoms. The trinuclear copper(II) complex (6)
was formed by coordination of the third Cu(II) ion with dianionic oxygen atoms of
each of two molecules of the mononuclear copper(II) complexes.
Fig. 1.2.10
Salem et al11
, have been reported synthesis of ligand derived from diacetyl
monoxime aroylhydrazones. The synthesized complexes have been characterized
by various physico chemical methods. In these complexes the oximate group
functions as a bridge between the two nickel(II) ions.
Fig. 1.2.11
35
Tumer et al12
, have been synthesized the amine compound
2-(2-aminoethyliminomethyl) phenol (H3A) as the starting material, and then they
prepared the polydentate Schiff base ligands from the reactions of the amine
compound (H3A) with phthalaldehyde (H2L), 4-methyl-2, 6-di-formlyphenol (H3L1)
and 4-t-butyl-2, 6-di-formylphenol (H3L2) in the ethanol solution. Moreover, the
complexes Cd(II), Cu(II), Co(II), Ni(II), Zn(II) and Sn(II) of the ligands H2L, H3L1
and H3L2 have been prepared. All compounds have been characterized by the
analytical and spectroscopic methods. In addition, the magnetic susceptibility and
molar conductance measurements have been made. The catalytic properties of the
mono- and binuclear Co(II) and Cu(II) complexes have been studied on the 3,5-di-
tert-butylcatechol (3, 5-DTBC) and ascorbic acid (aa) as a substrate. The oxidative
C–C coupling properties of the Co(II) and Cu(II) complexes have been investigated
on the sterically hindered 2, 6-di-tert-butylphenol (dtbp). The antimicrobial activity
properties of the ligands and their mono- and binuclear complexes have been studied
against the bacteria and fungi. The results were compared to the antibacterial and
fungi drugs. The TGA curves show that the decomposition takes place in three steps
for all complexes. Electrochemical properties of the complexes Cu(II) and Ni(II)
were investigated for the first time in acetonitrile by cyclic voltammetry.
Fig. 1.2.12
36
Shebl 13
have been synthesized the tetradentate N2O2 donor Schiff base ligand
by the condensation of 4, 6-diacetylresorcinol with benzyl amine. The structure of
the ligand was elucidated by elemental analyses, IR, 1H NMR, electronic and mass
spectra. Reaction of the Schiff base ligand with nickel(II), cobalt(II), iron(III),
cerium(III), vanadyl(IV) and uranyl(VI) ions in 1:2 molar ratio afforded binuclear
metal complexes. Also, reaction of the ligand with several copper(II) salts,
including Cl−, NO3
−, AcO
−, ClO4
− and SO4
2− afforded different metal complexes
that reflect the non-coordinating or weakly coordinating power of the ClO4− anion
as compared to the strongly coordinating power of SO4 2−
and Cl− anions.
Characterization and structure elucidation of the prepared complexes were achieved
by elemental and thermal analyses, IR, 1H NMR, electronic, mass and ESR spectra
as well as magnetic susceptibility measurements. The metal complexes exhibited
different geometrical arrangements such as square planar, octahedral, square
pyramidal and pentagonal bipyramidal arrangements. The variety in the geometrical
arrangements depends on the nature of both the anion and the metal ion.
Fig. 1.2.13
Emara et al14
, have reported the bifunctional carbonyl compound;
4, 6-diacetyl resorcinol (DAR) serves as precursor for the formation of different
Schiff base ligands, which are either di- or tetra-basic with two symmetrical sets of
either O2N or N2O tridentate chelating sites. The condensation of 4, 6-
37
diacetylresorcinol with 3-amino-1-propanol (3-AP) or 1, 3-diaminopropane (DAP),
yields the corresponding hexadentate Schiff base ligands, abbreviated as H4La and
H2Lb, respectively. The structures of these ligands were elucidated by elemental
analyses, IR, mass, 1H NMR and electronic spectra. Reaction of the Schiff base
ligands with copper(II), nickel(II), cobalt(II), zinc(II), cadmium(II), iron(III),
chromium(III), vanadyl(IV) and uranyl(VI) ions in 1:2 molar ratio afforded the
corresponding transition metal complexes. A variety of binuclear complexes for the
metal complexes were obtained with the ligands in its di- or tetra-deprotonated
forms. The structures of the newly prepared complexes were identified by elemental
analyses, infrared, electronic, mass, 1H NMR and ESR spectra as well as magnetic
susceptibility measurements and thermal gravimetric analysis (TGA). The bonding
sites are the azomethine and amino nitrogen atoms, phenolic and alcoholic oxygen
atoms. The metal complexes exhibit different geometrical arrangements such as
square planar, tetrahedral, square pyramid and octahedral arrangement.
Fig. 1.2.14
Annigeri et al15
, have synthesized a novel binuclear cobalt(II), nickel(II),
copper(II) and zinc(II) complexes of general composition [M2L(µ-Cl)Cl2].nH2O
with the Schiff-base ligand (where is the potential pentadentate ligands derived by
condensing 2, 6-diformyl-4-methylphenol with 4-amino-3-antipyrine) have been
38
synthesized and characterized. Analytical and spectral studies support the above
formulation. 1H-NMR and IR spectra of the complexes suggest that they have an
endogenous phenoxide bridge, with chloride as the exogenous bridge atom. The
electronic spectra of all the complexes are well characterized by broad d–d and a
high intensity charge-transfer transitions. The complexes are chloro-bridged as
evidenced by two intense far-IR bands centered around 270–280 cm-1
. Magnetic
susceptibility measurements show that complexes are antiferromagnetic in nature.
The compounds show significant growth inhibitory activity against fungi
Aspergillus niger and Candida albicans and moderate activity against bacteria
Bacillus cirroflagellosus and Pseudomonas auresenosa.
Fig. 1.2.15
Wang et al16
, have reported a new bis tridentate ligand 2,2’-bipyridine-3, 3’-
[2-pyridinecarboxamide] which can bind transition metal ions has been synthesized
via the condensation of 3, 3’-diamino-2, 2’-bipyridine together with 2-pyridine
carbonyl chloride. Two copper(II) coordination compounds have been prepared and
characterized: In the coordination geometry around both CuII ions is best described
as distorted trigonal bipyramidal where the remaining two coordination sites are
39
satisfied by hexafluoroacetylacetonate counter ions. The magnetic susceptibility
data for ligand (2-270 °K), reveal the occurrence of weak anti-ferromagnetic
interactions between the CuII ions.
Fig. 1.2.16
Krishnapriya et al17
, have reported a new ligand N, N-bis{3-(2-formyl-4-
methyl-phenol)-6-iminopropyl}oxamide (L) and its mono- and binuclear copper(II)
complexes have been synthesized and characterized. The ligand shows absorption
maxima at 249 and 360 with a weak transition at 455 nm. The ligand was found to be
fluorescent and shows an emission maximum at 516 nm on excitation at 360 nm. The
electronic spectra of the mono- and binuclear Cu(II) complexes exhibited a d–d
transition in the region 520–560 nm characteristic of square planar geometry around
Cu(II) ion. The ESR spectrum of the mononuclear complex showed four lines with
nuclear hyperfine splitting. The binuclear complex showed a broad ESR spectrum
with g = 2.10 due to anti-ferromagnetic interaction between the two Cu(II) ions. The
room-temperature magnetic moment values (μeff) for the mono- and binuclear Cu(II)
complexes are found to be 1.70 μB and 1.45 μB, respectively. The electrochemical
studies of the mononuclear Cu(II) complex showed a single irreversible one-electron
wave at −0.70V (Epc) and the binuclear Cu(II) complex showed two irreversible one-
electron reduction waves at −0.75V (E1pc) and −1.27V (E2pc) in the cathodic region.
40
Fig. 1.2.17
Seena et al18
, have reported five oxovanadium(IV) complexes of 2-hydroxy-
4-methoxybenzaldehyde nicotinic acid hydrazone (H2L1), 2-hydroxy-4-
methoxyacetophenone nicotinic acid hydrazone (H2L2) and a binuclear
oxovanadium(V) complex of H2L2 have been synthesized. These complexes were
characterized by different physicochemical techniques like electronic, infrared and
EPR spectral studies. The complexes [VOL1]2.H2O (1) and [VOL
2]2 .H2O (4) are
binuclear and [VOL1bipy] (2), [VOL
1phen] .1.5H2O (3) and [VOL2phen] .2H2O (6)
are heterocyclic base adducts and are EPR active. In frozen DMF at 77 K, all the
oxovanadium(IV) complexes show axial anisotropy with two sets of eight line
patterns. The complex [VOL2.OCH3]2 (5) is an unusual product and has distorted
octahedral geometry, as obtained by X-ray diffraction studies.
Fig. 1.2.18
41
Kiani et al19
, have synthesized the ligand derived from tetramethylfuranone,
and TMFPreH (TMFPreH=4-[3-(4-hydroxyimino-2, 2, 5, 5-dimethyl-dihydrofuran-
3-ylideneamino)-propylimino]-2, 2, 5, 5-tetramethyl-dihydrofuran-3(2H)-one
oxime) and its Cu(II) and Ni(II) complexes.
Fig. 1.2.19
Dede et al20
, have reported a new series of homo- and heteropolynuclear
copper(II) complexes of N,N″-bis[1-biphenyl-2-hydroxyimino-2-(4-acetylanilino)-
1-ethylidene]-diamines have been prepared and characterized by different
physical techniques. The starting point of the research was the reaction
of chloroacetyl chloride with biphenyl in the presence of aluminum
chloride. 4-biphenylhydroximoyl chloride was obtained by reacting
synthesized 4-(chloroacetyl) biphenyl with alkyl nitrite. Substituted
4-(alkylaminoisonitrosoacetyl) biphenyl (ketooxime) was prepared by reacting
4-biphenylhydroximoyl chloride with 4-aminoacetophenone in ethanol. Homodi-,
homotrinuclear and heterodinuclear copper(II) perchlorate complexes of
tetradentate Schiff bases which possess N4 donor sets derived from the
condensation of 4-(arylaminoisonitrosoacetyl)biphenyl and diamine derivatives
were synthesized and characterized. Elemental analysis, FT–IR, ESR, molar
conductivity, magnetic moment measurements and thermal analyses studies were
42
utilized for the investigation of the complexes. The free ligands were also
characterized by 1H- and
13C-NMR spectra. Elemental analyses, stoichiometric and
spectroscopic data of the metal complexes indicated that the metal: ligand ratio of
dinuclear copper(II) complexes were found to be 2 : 1 while this ratio was 3 : 2 in
trinuclear copper(II) complexes and the metal complexes indicated that the metal
ions are coordinated to the oxime and imine nitrogen atoms. The extraction abilities
of the novel ligands were also evaluated in chloroform by using several transition
metal picrates such as Mn2+
, Co2+
, Ni2+
, Cu2+
, Zn2+
, Pb2+
, Cd2+
, Hg2+
. It has been
observed that both ligands show a high affinity to Cu2+
ions.
Fig. 1.2.20
Jia et al21
, have reported the synthesis of three novel ternary copper(II)
complexes, [Cu2(phen)2(L-PDIAla)(H2O)2](ClO4)20.5H2O(1),Cu4(phen)6(D,L-
PDIAla)(H2O)2] (ClO4)6 3H2O (2) and [Cu2(phen)2(D,L-PDIAla)
(H2O)](ClO4)25H2O(3) (phen = 1,10-phenanthroline, H2PDIAla = N,N’-(p-
xylylene) di-alanine acid) have been synthesized and structurally characterized by
single-crystal X-ray crystallography and other structural analysis.
43
Fig. 1.2.21
Shebl et al22
, have reported the condensation of O-acetoacetylphenol and
1,2-diaminopropane in 1:1 molar ratio under condition of high dilution yielded the
mono-condensed dibasic Schiff base ligand with a N2O2 donors. The mono-
condensed ligand has been used for further condensation with 2-hydroxy-5-
nitrobenzaldehyde to obtain the new asymmetrical dicompartmental Schiff base
ligand, with N2O3 donors. The structure of the ligand was elucidated by analytical
and spectroscopic tools (IR, 1H and
13C NMR spectra) which indicated that the
coordinating sites are oxygen atoms of the phenolic OH groups, nitrogen atoms of
the azomethine groups and the oxygen atom of the ketonic group. The structures of
the complexes were characterized by various techniques such as elemental and
thermal analyses, IR, 1H and
13C NMR, mass and electronic spectra as well as
conductivity and magnetic moment measurements. Square-planar and octahedral
geometries are suggested for the Cu(II), Co(II) and Ni(II) complexes, octahedral
geometry for the Fe(III) and VO2+
complexes while uranium(VI) ion is octa-
coordinated in its complex. The Schiff base and its metal complexes were evaluated
for antimicrobial activity against Gram positive bacteria (Staphylococcus aureus),
Gram negative bacteria (Escherichia coli) and fungi (Candida albicans and
Aspergillus flavus). The ligand and some of its complexes were found to be
biologically active.
44
Fig. 1.2.22
Raman et al23
, (2010) have synthesized few novel binuclear Schiff base
metal complexes [M2LCl3], where M= Cu(II) and Zn(II); L=2, 6-bis-({2-[(3-
hydroxy-4-nitrobenzylidene) amino] ethylimino}methyl)-4-methylphenol(BHEM),
2, 6-bis-({2-[(3, 4-dimethoxybenzylidene)amino] ethylimino} methyl)-4-
methylphenol (BDEM) and 2, 6-bis-({2-[(2, 3, 5-richlorobenzylidene) amino]
ethylimino}methyl)-4-methylphenol (BTEM),have been synthesized and
characterized by analytical and spectral data. From the DNA cleavage study of
these complexes, investigated by gel electrophoresis, they found that they
efficiently cleave super coiled pUC19 DNA in the presence of a reducing agent (3-
mercaptopropionic acid) and on irradiation with UV light of 360 nm wavelength.
The mechanism reveals that singlet oxygen (1O2) plays a significant role in the
photo cleavage. The superoxide dismutase (SOD) mimetic activity of the
synthesized complexes demonstrates that most of the complexes have promising
SOD-mimetic activity. The antimicrobial study indicates that the complexes inhibit
the growth of bacteria and fungi more than the free ligands.
45
Fig. 1.2.23
Maity et al
24, have reported synthesis of ligand O-phenylenediamine with
diacetyl monoxime. The synthesized ligand and its metal complexes were
characterized by various physico-chemical methods. The metal centers were
connected via an oxygen-bridged arrangement.
Fig. 1.2.24
El-Hendawy et al25
,
have reported the synthesis of complexes
[M(Hdamsm)2]XH2O (M = Fe, X = NO3; M = Ru, X = Cl), [Ru(Hdamsm)
(PPh3)2X0](X0= Cl, Br), and [VO(Hdamsm)(acac)] (H2damsm =diacetylmonoxime
Schiff base of S-methyldithiocarbazate, Hacac = acetylacetone) have been prepared
and characterized by spectroscopic techniques. Their redox properties were
investigated by cyclic voltammetry. The X-ray crystal structure of
[Fe(Hdamsm)2]NO3.H2O has been determined and shows that the complex has a
46
distorted octahedral geometry in which the Hdamsm behaves as a monoanionic
NNS tridentate ligand coordinating via oxime nitrogen, hydrazinic imine nitrogen,
and thiolate sulfur. The reactivity of these complexes toward oxidation of alcohols
in the presence of t-BuOOH and H2O2 as co-oxidants is reported.
Fig. 1.2.25
Geeta et al26
, have reported a binucleating new Schiff-base ligand with a
phenylene spacer, afforded by the condensation of glycyl–glycine and
o-phthalaldehyde has been served as an octadentate N4O4 ligand in designing some
binuclear complexes of cobalt(II), nickel(II), copper(II), and palladium(II). The
binding manner of the ligand to the metal and the composition and geometry of the
metal complexes were examined by elemental analysis, conductivity measurements,
magnetic moments, IR, 1H,
13C NMR, ESR and electronic spectroscopies, and TGA
measurements. There are two different coordination/ chelation environments
present around two metal centers of each binuclear complex. The composition of
the complexes in the coordination sphere was found to be [M2(L)(H2O)4] (where
M = Co(II) and Ni(II)) and [M2(L)] (where M = Cu(II)and Pd(II)). In the case of
Cu(II) complexes, ESR spectra provided further information to confirm the
binuclear structure and the presence of magnetic interactions. All the above metal
complexes have shown moderate to good antibacterial activity against Gram-
positive and Gram-negative bacteria.
47
Fig. 1.2.26
Budagumpi et al27
, have synthesized Pyrazolyl diazine (-NN) bridged last
first row transition metal(II) complexes have been prepared by the interaction of
metal(II) chlorides with an ‘end-off’ compartmental Schiff base ligand. The ligand
system has a strong diazine bridging component and obtained as a condensation
product between 1Hpyrazole-3, 5-dicarbohydrazide and 3-acetylcoumarin in
absolute ethanol. All synthesized compounds were characterized on the basis of
various spectral and analytical techniques. Complexes are found to be non-
electrolytes and monomeric in nature. The magnetic exchange interactions were
very weak because of the more electronegative exogenous chloride, though diazine
bridging group bring metal centers in a close proximity.
Fig. 1.2.27
48
Prakash Naskar et al28
, have synthesized a novel ligand by the condensation
of an equimolar proportion of diacetyl-monoxime monohydrazone and
1-methylimidazole-2-carboxaldehyde in methanol gives rise to the imidazole
azine, 3-(1-methylimidazol-2-yl) methylenehydrazonobutan-2-one oxime(HL).
Reaction of 1:1stoichiometric proportion of HL with copper(II)perchlorate
hexahydrate in methanol yields a dimeric oximato bridged copper compound,
[Cu2L2(H2O)2](ClO4)2. The compound is characterized by C, H and N analyses,
FT-IR, ESI–MS, conductivity measurement, UV–Vis spectra and X-ray single
crystal diffraction. The geometry around each copper center is distorted square
pyramidal. The copper(II) dimer shows anti-ferromagnetic interaction mediated by
symmetric disposition of oximato groups.
Fig. 1.2.28
49
References
1. S. Parimala, K.N. Gita, M. Kandaswamy, Polyhedron 17 (1998) 3445.
2. R. Rajavel, Thesis Annamlai University 1999.
3. A.D. Lawrence, R.C. Howell, R. Young, I.A. Kahwa, Com. Biochem. Physio.
Part C 128 (2001) 119.
4. N. Saglam, A. Colak, K. Serbest, S. Dülger, S. Güner, S. Karaböcek,
A.O. Beldüz, BioMetals 15 (2002) 357.
5. N. Sengottuvelan, J. Manonmani, M. Kandaswamy, Polyhedron 21 (2002)
2767.
6. F. Tuna, Ionut G. Pascu, J. Pascal Sutter, M. Andruh, S. Joseph Guillevic,
H. Pritzkow, Inorg. Chim. Acta 342 (2003) 131.
7. R. Srinivasan, I. Sougandi, R. Venkatesan, P. Sambasiva Rao, Proc. Indian
Acad. Sci. (Chem. Sci.), 115(2) (2003) 91.
8. M. Bera, P. Kumar Nanda, U. Mukhopadhyay, D. Ray, J. Chem. Sci. 116(3)
(2004) 151.
9. S. Karabocek, N. Karabocek, A. Armutcu, Trans. Met. Chem. 31 (2006) 459.
10. N. Karabocek, A. Armutcu, S. Karabocek, Trans. Met. Chem. 31(2006) 938.
11. N.M.H. Salem, L. El-Sayed, S. Foro, W. Haase, M.F. Iskander, Polyhedron
26 (2007) 4161.
12. M. Tumer, D. Ekinci, F. Tumer, A. Bulut, Spectrochim. Acta A 67 (2007)
916.
13. M. Shebl, Spectrochim. Acta Part A 70 (2008) 850.
14. A.A.A. Emara, A.A. Saleh, O.M I. Adly, Spectrochim. Acta Part A 68 (2007)
592.
50
15. S.M. Annigeri, M.P. Sathisha V.K. Revankar Trans. Met. Chem 32 (2007) 81.
16. J. Wang, B. Djukic, J. Cao, A. Alberola, F.S. Razavi, M. Pilkington, Inorg.
Chem. 46(21) (2007) 8560.
17. K.R. Krishnapriya, D. Saravanakumar, P. Arunkumar, M. Kandaswamy,
Spectrochim. Acta Part A 69 (2008) 1077.
18. E.B. Seena, N. Mathew, M. Kuriakose, M.R. Prathapachandra Kurup,
Polyhedron (2008) 1455.
19. S. Kiani, R.J. Staples, S. Ted Treves, A.B. Packard, Polyhedron 28 (2009) 775.
20. B. Dede, F. Karipcin, M.J. Cengiz, Chem. Sci. 121(2) (2009) 163.
21. L. Jia, P. Jiang, J. Xu, Z. Hao, X. Xu, L. Chen, J. Wu, N. Tang, Q. Wang,
J. Vittal, J. Inorg. Chim. Acta 363 (2010) 855.
22. M. Shebl, S.M.E. Khalil, S.A. Ahmed, H.A.A. Medien, J. Mol. Struc. 980
(2010) 39.
23. N. Raman, A. Sakthivel, R. Jeyamurugan, Cent. Eur. J. Chem. 8(1) (2010) 96.
24. D. Maity, M.G.B. Drew, J. F. Godsell, S. Roy, G. Mukhopadhyay, Trans.
Met. Chem. 35 (2010)197.
25. A.M. El-Hendawy, A.M. Fayed, M.R. Mostafa, Trans. Met. Chem. 2011,
DOI 10.1007/ s11243-011-9477 0.
26. B. Geeta, K. Shravankumar, P.Muralidhar Reddy, E. Ravikrishna,
M. Sarangapani, K. Krishna Reddy, V. Ravinder, Spectrochim. Acta Part A
77 (2010) 911.
27. S. Budagumpi, V. K. Revankar Spectrochim. Acta Part A 77 (2010) 184.
28. J.Prakash Naskar, C. Biswas, L. Lu, M. J. Zhu, Chem. Crystallography 41
(2011) 502.
51
1.3 SCOPE OF THE PRESENT WORK AND OBJECTIVES
Schiff base metal complexes are an area of increasing interest. Because of
the presence of both hard nitrogen and oxygen soft sulphur atoms in the backbones
of these ligands, they are readily co-ordinate with a wide range of transition metal
ions yielding stable and intensely coloured metal complexes. These complexes have
numerous applications, such as, in the treatment of cancer, as antibactericide agents,
as antivirus agents, as fungicide agents and for other biological properties. The
design and development of potential therapeutic agents, particularly those designed
to target nucleic acids site specifically or to mimic the function of enzymes that
participate in nucleic acid strand cleavage can lead to safer and more rational
approaches to novel therapeutic agents for cancer, viral diseases and tools for
molecular biology. A bimetallic core is versatile at the active site of many
metalloenzymes and plays an essential role in biological systems by the interplay of
a pair of metal ions. The binuclear metal complex has greater cleaving efficiency
than mononuclear complex. For these applications, we are extending this field in
synthesis of novel binuclear Schiff base metal complexes.
The literature survey of the Schiff base complexes derived from
3, 3’diamino benzidine with 2, 3 butanedione monoxime, phthalaldehyde
monoxime and O-hydroxyacetophenone shows that no work has been reported
using these compounds.
The present study describes the synthesis, spectral, characterization, redox,
DNA binding, cleavage and anti-microbial activities of novel Schiff base binuclear
52
metal complexes obtained by the condensation of 3, 3’diaminobenzidine
with 2, 3 butanedione monoxime, phthalaldehyde monoxime and
O-hydroxyacetophenone.
Objectives of the study
1. Synthesis of binuclear Cu(II), Ni(II), Co(II) and Mn(II) Schiff base metal
complexes derived from 3, 3’diaminobenzidine with phthalaldehyde
monoxime, 2, 3 butanedione monoxime, O-hydroxyacetophenone by
conventional methodology as described in the literature.
2. The synthesized compounds are characterized by various physico-chemical
methods such as elemental analysis, molar conductance, IR, UV, NMR,
cyclic voltammetry, thermal, magnetic and EPR studies.
3. The synthesized compounds are screened for their anti-microbial activity
against Gram positive, Gram negative bacteria and fungi by well/ disc
diffusion method.
4. The CT- DNA binding with metal complexes were studied by using
absorption spectra, cyclic voltammetry and viscosity measurements.
5. pBR322-DNA cleavage of metal complexes was performed with Gel
electrophoresis method.